Botulism antitoxin heptavalent (A, B, C, D, E, F, G), Equine Injection
RxNorm 1722719

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1722719 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: botulism antitoxin heptavalent (A, B, C, D, E, F, G), Equine Injection.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Botulinum neurotoxin A immune FAB2, equine 4500 UNT / botulinum neurotoxin B immune FAB2, equine 3300 UNT / botulinum neurotoxin C immune FAB2, equine 3000 UNT / botulinum neurotoxin D immune FAB2, equine 600 UNT / botulinum neurotoxin E immune FAB2, equine 5100 UNT / botulinum neurotoxin F immune FAB2, equine 3000 UNT / botulinum neurotoxin G immune FAB2, equine 600 UNT Injection
Primary clinical definition
AUI:12333702
View
PSN
Botulism antitoxin heptavalent (A, B, C, D, E, F, G), Equine Injection
AUI:7709054
View
SY
Botulism antitoxin heptavalent (A, B, C, D, E, F, G), Equine Injection
AUI:7709055
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDPrescribable

Semantic Clinical Drug (SCD):
Botulinum neurotoxin A immune FAB2, equine 4500 UNT / botulinum neurotoxin B immune FAB2, equine 3300 UNT / botulinum neurotoxin C immune FAB2, equine 3000 UNT / botulinum neurotoxin D immune FAB2, equine 600 UNT / botulinum neurotoxin E immune FAB2, equine 5100 UNT / botulinum neurotoxin F immune FAB2, equine 3000 UNT / botulinum neurotoxin G immune FAB2, equine 600 UNT Injection
(Atom ID: 12333702)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
botulinum neurotoxin A immune FAB2, equine 4500 UNT / botulinum neurotoxin B immune FAB2, equine 3300 UNT / botulinum neurotoxin C immune FAB2, equine 3000 UNT / botulinum neurotoxin D immune FAB2, equine 600 UNT / botulinum neurotoxin E immune FAB2, equine 5100 UNT / botulinum neurotoxin F immune FAB2, equine 3000 UNT / botulinum neurotoxin G immune FAB2, equine 600 UNT Injection
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1722719
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12333702
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
1722719
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1722709} 1722696
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1722710} 1722683
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1722711} 1722698
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1722712} 1722700
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1722713} 1722702
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1722714} 1722704
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1722715} 1722706
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1722709} 1722696
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1722710} 1722683
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1722711} 1722698
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1722712} 1722700
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1722713} 1722702
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1722714} 1722704
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1722715} 1722706
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
4500 UNT / 3300 UNT / 3000 UNT / 600 UNT / 5100 UNT / 3000 UNT / 600 UNT
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{1722709} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1722710} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1722711} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1722712} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1722713} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1722714} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1722715} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
PSNPrescribable

Prescribable Name (PSN):
Botulism antitoxin heptavalent (A, B, C, D, E, F, G), Equine Injection
(Atom ID: 7709054)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
botulism antitoxin heptavalent (A, B, C, D, E, F, G), Equine Injection
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1722719
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
7709054
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1722719
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Botulism antitoxin heptavalent (A, B, C, D, E, F, G), Equine Injection
(Atom ID: 7709055)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
botulism antitoxin heptavalent (A, B, C, D, E, F, G), Equine Injection
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1722719
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
7709055
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1722719
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.